Company Filing History:
Years Active: 2021-2022
Title: Fuad Alnadwi: Innovator in Pharmaceutical Nanoemulsions
Introduction
Fuad Alnadwi is a prominent inventor based in Jeddah, Saudi Arabia. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative drug delivery systems. With a total of three patents to his name, Alnadwi is recognized for his pioneering work in nanoemulsions and 3D printing technologies.
Latest Patents
Alnadwi's latest patents include a groundbreaking essential oil nanoemulsion and methods of use thereof. This oil-in-water nanoemulsion comprises 8-12% w/v essential oil, 1-5% w/v polysorbate 80 surfactant, 2-6% w/v glyceryl citrate/lactate/linoleate/oleate co-surfactant, and 1-5% w/v glycerol monocaprylate, type I. The formulation allows for a surfactant and co-surfactant to essential oil ratio ranging from 1:1.1 to 1:1.6. Additionally, he has developed a self-nanoemulsifying 3D-printed tablet composition and method of use thereof. This invention includes a self-nanoemulsifying drug delivery system (SNEDDS) that incorporates glimepiride and/or rosuvastatin in a 3D-printed tablet format.
Career Highlights
Fuad Alnadwi is affiliated with King Abdulaziz University, where he conducts research and development in pharmaceutical innovations. His work focuses on enhancing drug delivery mechanisms to improve therapeutic outcomes for patients.
Collaborations
Alnadwi collaborates with esteemed colleagues such as Hossam H Tayeb and Raed Felimban, contributing to a dynamic research environment that fosters innovation in pharmaceutical sciences.
Conclusion
Fuad Alnadwi's contributions to the field of pharmaceutical innovations, particularly in nanoemulsions and 3D printing, highlight his role as a leading inventor. His work continues to pave the way for advancements in drug delivery systems, benefiting the healthcare industry.